✦ LIBER ✦

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement

✍ Scribed by B. I. ERIKSSON; L. BORRIS; O. E. DAHL; S. HAAS; M. V. HUISMAN; A. K. KAKKAR; F. MISSELWITZ; P. KÄLEBO; FOR THE ODIXA-HIP STUDY INVESTIGATORS

Book ID: 109149277
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 182 KB
Volume: 4
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2005.01657.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BAY 59-7939: an oral, direct Factor Xa i

BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

A phase II study of the oral factor Xa i

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

✍ G. AGNELLI; S. HAAS; J. S. GINSBERG; K. A. KRUEGER; A. DMITRIENKO; J. T. BRANDT 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Prevention of venous thromboembolism wit

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)

✍ B. I. ERIKSSON; A. G. G. TURPIE; M. R. LASSEN; M. H. PRINS; G. AGNELLI; P. KÄLEB 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

A dose escalation study of YM150, an ora

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

✍ B. I. ERIKSSON; A. G. G. TURPIE; M. R. LASSEN; M. H. PRINS; G. AGNELLI; P. KÄLEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

The direct thrombin inhibitor melagatran

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

✍ B. I. Eriksson; G. Agnelli; A. T. Cohen; O. E. Dahl; M. R. Lassen; P. Mouret; N. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

A new oral direct thrombin inhibitor, da

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

✍ B. I. ERIKSSON; O. E. DAHL; H. R. BÜLLER; R. HETTIARACHCHI; N. ROSENCHER; M-L. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB